Condition: Moderately to Severely Active Crohns Disease · Sponsor: Hoffmann-La Roche
This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).
This description comes directly from the study's public registry record.
Reference Study ID Number: GA45332 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Sun City Clinical Research | Glendale, Arizona, United States | Recruiting |
| Om Research LLC | Lancaster, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian;Hoag Center for Research and Education | Newport Beach, California, United States | Recruiting |
| Empire Clinical Research | Pomona, California, United States | Withdrawn |
| Stanford Medicine Outpatient Center | Redwood City, California, United States | Recruiting |
| Clinical Applications Laboratories, Inc. | San Diego, California, United States | Recruiting |
| Amicis Research Center | Santa Clarita, California, United States | Recruiting |
| Peak Gastroenterology Associates | Colorado Springs, Colorado, United States | Recruiting |
| J&A Clinical Research | Doral, Florida, United States | Recruiting |
| Auzmer Research | Lakeland, Florida, United States | Recruiting |
| Galenus Group Inc | Lehigh Acres, Florida, United States | Recruiting |
| Homestead Associates in Research, Inc. | Miami, Florida, United States | Recruiting |
+ 175 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06819891